A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
| Image |  |
|---|---|
| Description | scientific article published on June 10, 2013 |
| Author/s |
author: Gene P. Siegal Sejong Bae David T. Curiel Kenneth H Kim |
| Publication date | June 10, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |